Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine

Genetics: Expression signature identifies high-risk patients A gene expression signature identifies breast cancer patients who do poorly after endocrine therapy and might benefit from extra treatment. A team led by John Bartlett and Paul Boutros from the Ontario Institute for Cancer Research in Toro...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jane Bayani, Cindy Q. Yao, Mary Anne Quintayo, Fu Yan, Syed Haider, Alister D’Costa, Cassandra L. Brookes, Cornelis J. H. van de Velde, Annette Hasenburg, Dirk G. Kieback, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Daniel Rea, Paul C. Boutros, John M. S. Bartlett
Format: article
Langue:EN
Publié: Nature Portfolio 2017
Sujets:
Accès en ligne:https://doaj.org/article/e8e3e37c9ac342eb853c51e4f6f7efcc
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!